Diabetic Retinopathy Secondary to Diabetes: VA Disability Claim Guide

Overview

Diabetic retinopathy is one of the most common and medically straightforward secondary conditions associated with service-connected diabetes mellitus. It occurs when chronically elevated blood sugar levels damage the small blood vessels in the retina — the light-sensitive tissue at the back of the eye — leading to progressive vision impairment that can ultimately result in blindness if untreated.

The connection between diabetes and retinopathy is so well-established that it is considered a direct complication rather than merely an associated condition. The American Diabetes Association reports that diabetic retinopathy develops in virtually all patients with Type 1 diabetes and in over 60% of patients with Type 2 diabetes within 20 years of diagnosis. For veterans with service-connected diabetes, claiming retinopathy as a secondary condition is one of the strongest secondary claims available.

The VA rates compensable complications of diabetes separately from the diabetes rating itself, meaning a retinopathy rating is added to your existing diabetes rating rather than being absorbed into it. Even in early stages when vision may not yet be significantly affected, establishing service connection for retinopathy is strategically important because it creates a foundation for increased compensation as the condition progresses.

How Retinopathy Is Connected to Diabetes

The medical connection between diabetes and retinopathy is direct, causal, and undisputed in medical science:

Microvascular damage. Chronically elevated blood glucose levels damage the walls of the small blood vessels (capillaries) that supply the retina. This damage, known as microangiopathy, causes the vessels to leak fluid, blood, and lipid deposits into the retinal tissue. Research published in The New England Journal of Medicine has demonstrated that the duration and severity of hyperglycemia are the primary determinants of retinopathy development and progression.

Non-proliferative diabetic retinopathy (NPDR). In the early stages, damaged blood vessels develop microaneurysms — small bulges that can leak fluid into the retina. As the disease progresses, blood vessels become increasingly blocked, depriving areas of the retina of their blood supply. The retina responds by growing new, abnormal blood vessels (neovascularization), which marks the transition to proliferative disease. The Diabetes Control and Complications Trial (DCCT), a landmark study published in The New England Journal of Medicine, established that tight glucose control reduces but does not eliminate the risk of retinopathy development.

Proliferative diabetic retinopathy (PDR). In advanced stages, new abnormal blood vessels grow on the surface of the retina and into the vitreous (the gel-like substance filling the eye). These fragile vessels bleed easily, causing vitreous hemorrhage that can suddenly and severely impair vision. Scar tissue from these vessels can also pull on the retina, causing retinal detachment — a medical emergency that can lead to permanent blindness.

Diabetic macular edema (DME). Fluid leakage from damaged blood vessels can accumulate in the macula — the central part of the retina responsible for sharp, detailed vision. DME can occur at any stage of retinopathy and is the most common cause of vision loss in diabetic patients. Research in Ophthalmology documented that DME affects approximately 7% of diabetic patients overall and up to 29% of those with diabetes for 20 or more years.

Biochemical mechanisms. The pathways by which diabetes damages retinal blood vessels include oxidative stress, advanced glycation end-products (AGEs), protein kinase C activation, and inflammation. These mechanisms are extensively documented in research published in Progress in Retinal and Eye Research and provide the biochemical basis for the diabetes-retinopathy connection.

The prevalence data is compelling: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), one of the largest and longest-running studies on the topic, found that after 20 years of diabetes, approximately 99% of Type 1 patients and 60% of Type 2 patients develop some degree of retinopathy. This makes retinopathy one of the most predictable complications of diabetes.

Evidence Requirements

To claim diabetic retinopathy secondary to diabetes, you need:

• Current retinopathy diagnosis: A diagnosis from an ophthalmologist or optometrist based on a comprehensive dilated eye examination. The diagnosis should specify the type and stage — non-proliferative diabetic retinopathy (mild, moderate, or severe), proliferative diabetic retinopathy, or diabetic macular edema.
• Service-connected diabetes documentation: Your VA rating decision letter confirming diabetes mellitus is service-connected.
• Medical nexus letter: While the connection between diabetes and retinopathy is well-established, a nexus letter strengthens your claim. An ophthalmologist’s statement that your retinopathy is a direct complication of your diabetes is typically sufficient.
• Eye examination records: Documentation of dilated eye exams, including fundoscopy findings, optical coherence tomography (OCT) results, fluorescein angiography (if performed), and visual acuity measurements.
• Visual acuity records: Documented best-corrected visual acuity for each eye. If visual acuity is impaired, these measurements directly determine your rating.
• Visual field testing (if applicable): If retinopathy has affected your peripheral vision, visual field testing (Goldmann or automated perimetry) documents the extent of field loss.
• Diabetes treatment records: Documentation showing your diabetes history, A1C levels, treatment regimen, and how well blood sugar has been controlled. These records support the connection between your diabetes and retinopathy.
• Lay statements: Personal descriptions of how vision changes affect your daily life — difficulty reading, driving at night, recognizing faces, performing work tasks, and any falls or accidents related to impaired vision.

Nexus Letter Tips

Because the connection between diabetes and retinopathy is medically undisputed, the nexus letter for this claim can be more straightforward than for other secondary conditions:

Who should write it: An ophthalmologist is the ideal choice. An optometrist who has been managing your diabetic eye disease can also provide an effective letter. Your treating endocrinologist or primary care physician can also write a nexus letter, as any physician understands the diabetes-retinopathy connection.

Essential content: The letter should state that your diabetic retinopathy is “at least as likely as not” caused by your service-connected diabetes mellitus. Include:

1. The provider’s credentials and relevant ophthalmic expertise
2. Confirmation of a clinical examination and review of medical records
3. Your specific retinopathy diagnosis with staging
4. Current visual acuity measurements and any visual field findings
5. Explanation that diabetic retinopathy is a direct microvascular complication of diabetes mellitus, caused by chronic hyperglycemia damaging retinal blood vessels
6. Citation of major research (DCCT, WESDR, UKPDS) establishing the diabetes-retinopathy connection
7. Your diabetes history showing the duration and severity needed to develop retinopathy
8. The correct legal standard language

Simplicity advantage: Unlike many secondary claims where the medical connection is debated, the diabetes-retinopathy connection is universally accepted. The nexus letter does not need to argue the connection exists — it simply needs to confirm that your specific retinopathy is a complication of your specific diabetes.

Rating Criteria for Diabetic Retinopathy

Diabetic retinopathy is rated under Diagnostic Code 6006. The rating depends on whether vision is impaired:

Active pathology without visual impairment:

• 10% — Retinopathy diagnosed with active pathology (microaneurysms, hemorrhages, exudates) but without compensable visual impairment. This is the minimum rating for active diabetic retinopathy.

Based on visual acuity impairment (DC 6061-6066):

• Ratings from 10% to 100% based on corrected visual acuity in each eye. For example, 20/50 in one eye with 20/40 in the other is rated 10%. 20/200 in one eye with 20/40 in the other is rated 20%. Complete blindness in both eyes is rated 100%.

Based on visual field loss (DC 6080):

• 10% to 100% based on the extent of visual field contraction. Concentric contraction to 60 degrees but not to 45 degrees bilaterally is rated 10%. Concentric contraction to 5 degrees bilaterally is rated 100%.

Based on incapacitating episodes:

• Retinopathy requiring bed rest prescribed by a physician may be rated based on the total duration of incapacitating episodes during a 12-month period, from 10% (at least 1 week) to 60% (at least 6 weeks).

Important note: As retinopathy progresses and vision worsens, your rating can be increased. This is why establishing service connection early — even at 10% — is strategically valuable. Diabetic retinopathy is a progressive condition, and having an established service-connected rating means you only need to file for an increase rather than proving the entire connection again.

C&P Exam Tips

The C&P exam for diabetic retinopathy will be conducted by an ophthalmologist or optometrist and will include a comprehensive eye examination:

• Bring your current glasses or contacts. Visual acuity is measured with best correction. Bring your most current prescription eyewear.
• Bring eye examination records. Copies of recent dilated eye exams, OCT results, and any prior retinopathy documentation ensure the examiner has complete information.
• Report all vision symptoms. Describe blurry vision, floaters, dark spots, difficulty seeing at night, loss of color vision, difficulty reading, and any sudden vision changes. Be specific about which eye is affected and how symptoms impact daily activities.
• Describe functional impact. Explain how vision changes affect your daily life — difficulty driving (especially at night), reading, using a computer, recognizing faces, navigating stairs, and performing work tasks. Functional impact is critical for higher ratings.
• Mention any treatment you have received. Report all retinopathy treatments — laser photocoagulation, anti-VEGF injections (Avastin, Lucentis, Eylea), vitrectomy surgery, or monitoring schedule. Treatment history demonstrates the severity and active nature of the condition.
• Discuss diabetes management. The examiner may ask about your diabetes control. Be honest about your A1C levels and treatment adherence. Poorly controlled diabetes supports the connection to retinopathy, though well-controlled diabetes does not disqualify you — retinopathy can develop even with good control.
• Report both eyes separately. Retinopathy may affect your eyes differently. Describe symptoms and limitations for each eye individually.
• Do not wear dark glasses inside. Unless you have a medical need, wearing dark glasses during the exam may prevent the examiner from fully assessing your condition.

Impact on Combined Rating

Adding a retinopathy rating to your existing diabetes rating increases your combined VA disability:

Example scenario: A veteran has a 20% diabetes rating and receives 10% for retinopathy.

1. Start with 20%: remaining ability = 80%
2. Apply 10%: 10% of 80 = 8, running total = 28%
3. Rounds to 30% under VA rounding rules

Example with multiple diabetes complications: A veteran has 20% diabetes, 10% retinopathy, 20% peripheral neuropathy (bilateral), and 10% hypertension:

1. Start with 20% diabetes: remaining = 80%
2. Apply 20% neuropathy: 20% of 80 = 16, running total = 36%, remaining = 64%
3. Apply 10% retinopathy: 10% of 64 = 6.4, running total = 42.4%, remaining = 57.6%
4. Apply 10% hypertension: 10% of 57.6 = 5.76, running total = 48.16%, rounds to 50%

The bilateral factor would also apply to bilateral peripheral neuropathy, potentially pushing the combined rating higher. Diabetes with multiple service-connected complications is a strong path to higher overall combined ratings, and retinopathy is one of the easiest complications to establish.

Progressive nature: Diabetic retinopathy typically worsens over time. The 10% initial rating can increase substantially if vision deteriorates — particularly if you require VEGF injections, laser treatment, or surgery. Monitoring your condition and filing for increases as warranted is important.

For personalized guidance on your VA disability claim, consult a VA-accredited VSO, attorney, or claims agent.